The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access ...

GoodRx has been hit with a series of antitrust class actions in California and Rhode Island federal courts challenging the ...

GoodRx and pharmacy benefit managers CVS Caremark, Express Scripts, MedImpact and Navitus Health Solutions are facing class-action lawsuits accusing them of colluding to super press reimbursements to ...

The two other cases name them as well as PBMs CVS Caremark (NYSE:CVS), Express Scripts, which is owned by Cigna (NYSE:CI), ...

According to the company, effective January 1, 2025, cyclosporine ophthalmic solution 0.1% (Vevye) will be included on key ...

CVS Pharmacy Inc. and the former president of Cigna Corp.'s Express Scripts asked a federal judge to amend an injunction ...

Express Scripts said the legal action was "reckless ... chief legal officer at Cigna. CVS Caremark said that preventing PBMs from negotiating drug prices will only benefit pharma companies ...

Because of my background in specialty pharmacy work and passion for medicine, I was driven to the field and able to see ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...